Gyamfi-Bannerman C, Jablonski KA, Blackwell SC et al. Evaluation of hypoglycemia in neonates of women at risk for late preterm delivery: an antenatal late pretermsteroids trial cohort study. Am J Perinatol 2023;40(5):532–538. DOI: 10.1055/s-0041-1729561
Battarbee AN, Clapp MA, Boggess KA, et al. Practice variation in antenatal steroid administration for anticipated late preterm birth: a physician survey. Am J Perinatol 2019;36(2):200–204. DOI: 10.1055/s-0038-1667028
Asztalos EV, Murphy KE, Matthews SG. A growing dilemma: antenatal corticosteroids and long-term consequences. Am J Perinatol 2022;39(6):592–600. DOI: 10.1055/s-0040-1718573
Chawla S, Wyckoff MH, Rysavy MA, et al. Association of antenatal steroid exposure at 21 to 22 weeks of gestation with neonatal survival and survival without morbidities. JAMA Network Open 2022;5(9):e2233331. DOI: 10.1001/jamanetworkopen.2022.33331
Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org; Reddy UM, Deshmukh U, et al. Society for Maternal-Fetal Medicine consult series #58: use of antenatal corticosteroids for individuals at risk for late preterm delivery: replaces SMFM statement #4, implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery, August 2016. Am J Obstet Gynecol 2021;225(5):B36–B42. DOI: 10.1016/j.ajog.2021.07.023
Liauw J, Hannah Foggin H, Socha P, et al. Technical update no. 439: antenatal corticosteroids at late preterm gestation. J Obstet Gynaecol Can 2023;45(6):445–457. DOI: 10.1016/j.jogc.2022.12.006
Norman J, Shennan A, Jacobsson B, et al. FIGO good practice recommendations on the use of prenatal corticosteroids to improve outcomes and minimize harm in babies born preterm. Int J Gynaecol Obstet Int J Gynaecol Obstet 2021;155(1):26–30. DOI: 10.1002/ijgo.13836. Erratum in: 2022;157(2):486.
